Charles River Laboratories International, INC. (CRL) SEC Filings — 2025

Filings

• Charles River Labs Appoints George Blankenship to Board — 8-K · Dec 3, 2025
• Charles River Labs Appoints George Blankenship to Board — 8-K · Nov 17, 2025
• Charles River Labs Sees Q3 Net Income Dip 22% Amid Revenue Stagnation — 10-Q · Nov 5, 2025
• Charles River Labs Files 8-K Amendment on Officer/Director Changes — 8-K/A · Sep 19, 2025
• Charles River Labs Director Departs; Officer Comp & Reg FD Disclosed — 8-K · Sep 16, 2025
• Charles River Labs Posts Strong Q2 Growth, Net Income Up 12% — 10-Q · Aug 6, 2025
• Charles River Labs Adds New Directors, Approves Compensatory Plans — 8-K · May 23, 2025
• Charles River Labs Files Q1 2025 10-Q — 10-Q · May 7, 2025
• Charles River Labs Files 8-K: Agreements, Personnel Changes — 8-K · May 7, 2025
• Charles River Labs Files 2025 Proxy Statement — DEF 14A · Apr 2, 2025
• Charles River Labs Files 8-K — 8-K · Feb 21, 2025
• Charles River Labs Files 8-K on Financials — 8-K · Feb 19, 2025
• Charles River Labs Files 8-K — 8-K · Jan 14, 2025